The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
51
345: The sudden withdrawal of a CDC nominee and...
30 min
52
344: Trump's FDA commissioner nominee takes the...
24 min
53
343: Turbulence at the FDA, Bluebird Bio's sale...
31 min
54
342: FDA cuts, zombie biotechs, and too much we...
40 min
55
341: NIH funding cuts, a U.S. brain drain, and ...
25 min
56
340: Crisis in CRISPR world, RFK Jr.'s promises...
33 min
57
339: RFK Jr.'s confirmation hearings, MASH drug...
33 min
58
338: Chinese biotechs, a WHO departure, and pos...
32 min
59
337: Eli Lilly CEO on Trump, obesity drugs, and...
58 min
60
336: Pharma's big patent cliff, more obesity fu...
32 min
61
335: A deep dive on Makary, Vertex's pain data,...
33 min
62
334: Pharma silence on RFK Jr. & parents trying...
34 min
63
333: An H5N1 bird flu update and talent scarcit...
27 min
64
332: Pfizer's new R&D head, a VC deep-dive, and...
35 min
65
331: AbbVie’s stumble, Amgen’s tumble and more ...
30 min
66
330: How a Trump presidency could affect the FD...
39 min
67
329: Lilly's earnings surprise, investors mull ...
28 min
68
328: Pfizer's activist troubles, gene therapy q...
33 min
69
327: Biotech's next gold rush, GLP-1 shortages,...
34 min
70
326: Crypto for CRISPR, a new RNAi startup, & a...
40 min
71
325: Biden's health care AI czar, a new obesity...
32 min
72
From Tradeoffs: Race to the Bottom
28 min
73
324: Genentech's cancer pivot, Pfizer's sickle ...
32 min
74
323: Cannabinoids for weight loss, a cancelled ...
35 min
75
322: A new threat to Merck's blockbuster cancer...
32 min